Ernesto Zedillo - Procter Gamble Independent Director
| PG Stock | MXN 2,777 39.58 1.45% |
Director
Dr. Ernesto Zedillo Ph.D. is an Independent Director of the Procter Gamble Company. Dr. Zedillo served as President of Mexico from 1994 to 2000 and currently serves as Director of the Center for the Study of Globalization and Professor in the field of International Economics and Politics at Yale University. He was a Director of Alcoa Inc. since 2002 and Citigroup Inc. and Promotora de Informaciones S.A. since 2010. Dr. Zedillo was also a Director of Union Pacific Corporation from 2001 to 2006 since 2001.
| Age | 62 |
| Tenure | 23 years |
| Phone | 513 983 1100 |
| Web | https://www.pginvestor.com |
Ernesto Zedillo Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ernesto Zedillo against Procter Gamble stock is an integral part of due diligence when investing in Procter Gamble. Ernesto Zedillo insider activity provides valuable insight into whether Procter Gamble is net buyers or sellers over its current business cycle. Note, Procter Gamble insiders must abide by specific rules, including filing SEC forms every time they buy or sell Procter Gamble'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ernesto Zedillo over three months ago Acquisition by Ernesto Zedillo of 2254 shares of Citigroup subject to Rule 16b-3 | ||
Ernesto Zedillo over a year ago Acquisition by Ernesto Zedillo of 2478 shares of Procter Gamble subject to Rule 16b-3 |
Procter Gamble Management Efficiency
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3202 %, meaning that it generated $0.3202 on every $100 dollars invested by stockholders. Procter Gamble's management efficiency ratios could be used to measure how well Procter Gamble manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| George Liarokapis | LOral SA | N/A | |
| Jose Rodriguez | Kimberly Clark de Mxico | N/A | |
| Bernard Kasriel | LOral SA | 72 | |
| Jose Cordova | Kimberly Clark de Mxico | N/A | |
| CharlesHenri Filippi | LOral SA | 64 | |
| Emilio Gamboa | Kimberly Clark de Mxico | 81 | |
| Antonio Arino | Kimberly Clark de Mxico | 84 | |
| Esteban Fomperosa | Kimberly Clark de Mxico | 70 | |
| Mark Buthman | Kimberly Clark de Mxico | 55 | |
| Jorge Franco | Kimberly Clark de Mxico | 69 | |
| Javier Moral | Kimberly Clark de Mxico | N/A | |
| Eileen Naughton | LOral SA | 60 | |
| Maria Henry | Kimberly Clark de Mxico | 53 | |
| JeanVictor Meyers | LOral SA | 31 | |
| Jesus Urevig | Kimberly Clark de Mxico | N/A | |
| Virginie Morgon | LOral SA | 48 | |
| Sophie Bellon | LOral SA | 56 | |
| Ana Amaral | LOral SA | 52 | |
| Michael Hsu | Kimberly Clark de Mxico | 54 | |
| Louis Schweitzer | LOral SA | 73 | |
| Carlos Curiel | Kimberly Clark de Mxico | N/A | |
Management Performance
| Return On Equity | 0.32 | |||
| Return On Asset | 0.0955 |
Procter Gamble Leadership Team
Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kathleen Fish, Chief Research, Development and Innovation Officer | ||
| Craig Buchholz, Chief Communications Officer and Vice President – Communications, Personal Health Care and Oral Care | ||
| Matthew Janzaruk, VP Officer | ||
| Mary FergusonMcHugh, Group President - Global Family Care and Global Brand Creation and Innovation, P&G Ventures | ||
| Kenneth Chenault, Independent Director | ||
| Debra Lee, Independent Director | ||
| Mindy Sherwood, President Global Walmart | ||
| Amy Chang, Independent Director | ||
| Nelson Peltz, Independent Director | ||
| Martin Riant, Group Pres and Advisor to the CEO | ||
| Hatsunori Kiriyama, President - Asia | ||
| Magesvaran Suranjan, President - Asia Pacific Selling and Market Operations | ||
| Kirti Singh, Chief Analytics and Insights Officer | ||
| Tarek Farahat, President - Latin America | ||
| Francis Blake, Independent Director | ||
| Thomas Finn, President - Personal Health Care | ||
| Mohamed Samir, President - India, Middle East and Africa | ||
| Alexandra Keith, President - Global Hair Care and Beauty Sector | ||
| Susan DesmondHellmann, Independent Director | ||
| Valarie Sheppard, Controller and Treasurer and Executive Vice President - Company Transition Leader | ||
| Fama Francisco, Chief Executive Officer - Baby and Feminine Care | ||
| Loic Tassel, President - Europe | ||
| Margaret Whitman, Independent Director | ||
| Walter McNerney, Lead Independent Director | ||
| Terry Lundgren, Independent Director | ||
| Shelly McNamara, Senior Vice President of Human Resources | ||
| Angela Braly, Independent Director | ||
| Giovanni Ciserani, Group President of Global Fabric and Home Care and Global Baby and Feminine Care | ||
| M Grabowski, Chief Human Resource Officer | ||
| Javier Polit, Chief Information Officer | ||
| B Allen, Independent Director | ||
| James McNerney, Lead Independent Director | ||
| Ernesto Zedillo, Independent Director | ||
| Steven Bishop, Chief Executive Officer - Health Care | ||
| Scott Cook, Independent Director | ||
| Henry Karamanoukian, President Go-to-Market, China and Hair Care, Greater China | ||
| Sundar Raman, President - Fabric Care, North America and P&G Professional, Global | ||
| Ernesto Leon, Independent Director | ||
| Susan Whaley, Chief Sec | ||
| R Keith, Chief Executive Officer - Beauty | ||
| Yannis Skoufalos, Global Product Supply Officer | ||
| Linda ClementHolmes, CIO | ||
| Jennifer Davis, President - Feminine Care | ||
| John Chevalier, Director - Investor Relations | ||
| Juan Posada, President - Latin America Selling and Market Operations | ||
| Fatima Francisco, Feminine Baby | ||
| Alan Lafley, Executive Chairman and Member of Proxy Committee | ||
| Jeffrey Schomburger, Global Sales Officer | ||
| Monica Turner, Senior Vice President - Sales, North America | ||
| Vittorio Cretella, Chief Information Officer | ||
| Christine McCarthy, Independent Director | ||
| Patricia Woertz, Independent Director | ||
| Shailesh Jejurikar, Chief Executive Officer - Fabric and Home Care | ||
| Philip Duncan, Chief Design Officer | ||
| Andre Schulten, Chief Officer | ||
| Marc Pritchard, Global Brand Building Officer | ||
| Markus Strobel, President - Skin & Personal Care | ||
| David Taylor, Chairman of the Board, President, Chief Executive Officer | ||
| Mark Biegger, Global Human Resources Officer | ||
| Joseph Jimenez, Independent Director | ||
| Matthew Price, President - Greater China Selling and Market Operations | ||
| Julio Nemeth, President - Global Business Services | ||
| Laura Becker, President - Global Business Services | ||
| Deborah Majoras, Chief Legal Officer, Secretary | ||
| Jon Moeller, Vice Chairman of the Board, Chief Financial Officer | ||
| Charles Pierce, Group President - Global Grooming | ||
| Gary Coombe, President - Europe Selling and Market Operations | ||
| Carolyn Tastad, Group President - North America and Chief Sales Officer | ||
| Ken Patel, Chief Counsel |
Procter Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.32 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 7.61 T | |||
| Shares Outstanding | 2.36 B | |||
| Shares Owned By Insiders | 0.12 % | |||
| Shares Owned By Institutions | 65.88 % | |||
| Price To Earning | 25.58 X | |||
| Price To Book | 8.32 X |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Procter Gamble using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in The Procter Gamble. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For more information on how to buy Procter Stock please use our How to Invest in Procter Gamble guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Procter Stock analysis
When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |